Whitney Economics Estimates US Cannabis Production Surpasses 48.8 Million Pounds

Dec.09.2022
Whitney Economics Estimates US Cannabis Production Surpasses 48.8 Million Pounds
Whitney Economics predicts US cannabis sales will reach $29.3 billion by 2022 and $81.6 billion by 2030.

According to a new report by Whitney Economics, the total production of marijuana in the United States exceeds 48.8 million pounds.


The data included in the "2022 US Marijuana Supply Report" covers both legal and illegal markets and spans all product types, such as flowers, concentrates, and edibles.


Beau Whitney, founder and chief economist of Whitney Economics, has stated that the total supply has slightly increased compared to 2021. He added that the supply and demand are well balanced this year.


Whitney stated that some growers in Northern California and Southern Oregon had successful harvests and planted more crops, "but the typical practice is if they have an oversupply one year, they will not plant as much the following year. This has been confirmed through my interviews in legacy fields and with regulatory agencies in multiple states.


According to Whitney Economics, the total sales of legal marijuana are expected to reach $29.3 billion by 2022 and $81.6 billion by 2030. The company also predicts that starting in 2026, the legal supply will surpass the illegal supply.


Related: These eight states sold $12.8 billion in adult-use cannabis in 2021.


Whitney stated that if the current legal cultivation capacity in the United States reached 100%, it would be approximately 1.5 times the total demand for cannabis in the country.


Whitney stated that some believe "unlimited demand, unlimited permission - this is the best option," but Whitney Economics strongly opposes this view. While it may be applicable to a national market, in the current context of isolated systems within individual countries, it can easily lead to overproduction and a surplus of supply compared to demand.


Michigan serves as a perfect example of the current state of the marijuana industry in states like Oregon, Colorado, and California. With supply outweighing demand, prices are being driven down, resulting in cutthroat competition that harms small businesses, women-owned businesses, and minority-owned businesses, ultimately squeezing out profits. However, multi-state operators (MSOs) are benefiting from this situation as they have the resources to sustain fierce competition and acquire necessary funds.


Whitney Economics has proposed to regulatory agencies an annual adjustment of supply capacity based on the schedule of each project, according to Whitney.


By avoiding the risk of oversupply, this creates a healthier, stronger, and more successful market," stated Whitney. "The purpose of this approach is to encourage consumers to enter the legal market because the prices are reasonable, without causing operators to fail. Therefore, it is a modified limited licensing model rather than an arbitrary one. The countries we have been discussing this with are very interested in learning more about the model.


Whitney stated that the state of Illinois is an example of a state that could benefit from more licenses. "They do have limited licenses there and they just need more. They need more supply, they need more opportunities," he said. "They limit the amount of retail stores so consumers don't have as much access. They just say, 'Well, I'm not going to drive 30, 40, 50 minutes to get marijuana when I can get it quicker through illegal channels.'


Therefore, our recommendation for the state of Illinois is to increase supply capacity and the number of retail stores, in order to make the produced supply more accessible to a larger number of consumers.


According to Whitney, the growth projections outlined in the new report assume that states with medical or adult-use programs will increase to meet the demands of consumers and patients. Additionally, cannabis will become more normalized, either through federal legalization or interstate commerce.


He said that inflation may affect the future supply and demand of marijuana and has already started to impact the decline of consumer behavior.


Furthermore, due to oversupply in many of these states, prices are decreasing. As a result, retailers may sell the same amount of marijuana but at a cheaper price. The amount consumers are spending now is not entirely the same," Whitney said.


But where inflation really hits the cannabis industry is in the startup costs," he said. These costs include facility construction, PVC piping, HVAC systems, and more.


According to Whitney, in mature markets, people are buying existing businesses instead of creating new ones, so inflation won't play a role in the building industry's inflation. However, in new markets like future New York, New Jersey, Maryland, Missouri, and Pennsylvania- states with high populations- the growth rate of the entire market is significant. These markets might restrain sales, not because demand is absent, but because supply is scarce, and operators have a difficult time starting up.


Related: The decrease in marijuana prices exacerbates inflation in the market.


Whitney stated that the future that the industry needs is a transition from independent supply chains in each state to allowing marijuana businesses across the country to collaborate legally and compliantly.


At the federal level, there is a compelling case being made for some more prominent issues, particularly with regard to the SAFE Banking Act, interstate commerce, and tax reform under Section 280E - all of which impact the industry," Whitney stated.


2FIRSTS will continue to track and report on this issue. Further updates will be available on the "2FIRSTS APP." Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea’s Ministry of Food and Drug Safety said on April 17 that it has additionally designated the International Characterization Research Institute as a tobacco harmful components testing body under the Act on the Management of Tobacco Harmfulness. The institute has research experience in analyzing harmful components in liquid e-cigarettes and has obtained recognition for tobacco-sector ISO 17025 requirements.
Apr.17 by 2FIRSTS.ai
ITGA Americas Meeting Calls for Balanced Regulation as Tobacco Growers Warn of Pressure on Farms and Legal Supply Chains
ITGA Americas Meeting Calls for Balanced Regulation as Tobacco Growers Warn of Pressure on Farms and Legal Supply Chains
ITGA said tobacco grower organizations from five Americas countries called for stronger regional cooperation and balanced regulation, warning that restrictive policies could pressure farmers and legal supply chains. The article also provides data on major tobacco-producing countries in the Americas.
Special Report
Jun.02
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
According to Better Retailing, Philip Morris International (PMI) has launched Zyn Menthol Ice 16.5mg in the UK, marking the highest-strength nicotine pouch in the Zyn range to date. The eucalyptus- and menthol-flavored product is now available through PMI Open and will begin rolling out to wholesale channels from the end of May.
PMI
May.28
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
British American Tobacco New Zealand said the illicit tobacco trade is responsible for its profit halving and revenue falling between the 2024 and 2025 financial years. Financial results filed with the Companies Office show that BAT Holdings (New Zealand) recorded 2025 revenue of NZ$180.7 million, or about US$106.95 million based on the European Central Bank’s April 27, 2026 reference rates, down from NZ$254 million, or about US$150.33 million, in 2024.
Apr.28 by 2FIRSTS.ai
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium Approves Vape Flavor Ban, Allowing Only Tobacco-Flavored and Unflavored Products From September 2028
Belgium’s federal government on Thursday approved a ban on flavored vapes, allowing only tobacco-flavored and unflavored e-cigarettes on the market from September 2028. Health Minister Frank Vandenbroucke said the measure is aimed at protecting the health of children and young people and preventing a new generation from becoming dependent on tobacco.
May.06 by 2FIRSTS.ai